Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04896112
Title A Study of LNK01002 in Patients With Primary (PMF) or Secondary Myelofibrosis (PV-MF, ET-MF) or Acute Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Lynk Pharmaceuticals Co., Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Revive Research Institute Farmington Hills Michigan 48334 United States Details
Revive Research Institute Sterling Heights Michigan 48314 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field